Company

Red Arrow Therapeutics

Biotechnology Research Cambridge, Massachusetts, United States 8 employees

Employees: 8
Contacts: 3
Emails: 3
Phones: 3

redarrowtx.com LinkedIn Crunchbase

Red Arrow Therapeutics Overview

Headquarters: Cambridge, Massachusetts, United States
Website: redarrowtx.com
Industry: Biotechnology Research
Employees: 8
Founded: 2021
Funding: 4.5M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

biotechnology drug delivery oncology immuno-oncology

About Red Arrow Therapeutics

Red Arrow Therapeutics, Inc. is a biotechnology company focusing on developing new technologies that can turn "cold" tumors into inflamed "hot" tumors. Red Arrow Therapeutics' lead product candidate, RA-001, a pH-activated polymer micelle loaded with IL-12, is designed to release fully active IL-12 upon sensing intratumoral pH to safely potentiate immunotherapy. In the current pre-clinical data, RA-001 exhibits strong anti-tumor immunity in various tumor models. Furthermore, RA-001 shows high efficacy as monotherapy and in combination with immune checkpoint inhibitors.

Red Arrow Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 3; 75.0% coverage

Red Arrow Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Hiroaki (Koby) Kobayashi, Md/mba	Partner at Utec	Greater Tokyo Area, Japan	Email Phone
Rika Tajima	CEO, Co-founder@ Red Arrow Therapeutics		View
Jicai Huang	Fellow at Nektar Therapeutics	San Mateo, California, United States	Email Phone
Shant Nepal, Ph.d.	Research Scientist - Biomedical Engineering	Tokyo, Japan	Email Phone